Abstract
One of the worst public health crises facing humanity, the HIV/AIDS epidemic has had and continues to have profound social, political, economic, and health impact on individuals, their communities, our nation, and the world. In the United States, over the past 35 years, we have significantly changed our public health and epidemiologic surveillance systems of infectious diseases, implemented new policies for keeping our blood supply safe, developed new procedures and guidelines for HIV testing and treatment, intervened in people’s most private behaviors, attempted to mitigate the devastating and relentless stigma, developed and tested numerous vaccines—although at present, none have proven effective—developed safe and effective antiretroviral drug therapies that treat HIV disease and are now being used to prevent HIV infection, and recently—in 2010 and updated in 2015—established a National HIV/AIDS Strategy. We have made significant and innovative gains in terms of new knowledge generated, cases averted and length and quality of life for those afflicted; yet HIV/AIDS remains as the most serious, national public health crisis in the United States with incidence remaining at approximately 50,000 people newly infected each year (Centers for Disease Control and Prevention [CDC] 2013a).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
AIDS.gov. (n.d.). A timeline of AIDS—AIDS.gov. Retrieved October 4, 2014, from http://www.aids.gov/hiv-aids-basics/hiv-aids-101/aids-timeline/.
Altman, L. K. (1981). Rare cancer seen in 41 homosexuals. (1981, July 3). The New York Times. Retrieved July 22, 2014, from http://www.nytimes.com/1981/07/03/us/rare-cancer-seen-in-41-homosexuals.html?&pagewanted=2.
Altman, L. K. (1984). New U.S. report names virus that may cause AIDS. The New York Times. Retrieved October 13, 2014, from http://www.nytimes.com/1984/04/24/science/new-us-report-names-virus-that-may-cause-aids.html.
Auerbach, D. M., Darrow, W. W., Jaffe, H. W., & Curran, J. W. (1984). Cluster of cases of the acquired immune deficiency syndrome: Patients linked by sexual contact. The American Journal of Medicine, 76(3), 487–492.
Barré-Sinoussi, F., Chermann, J. C., Rey, F., Nugeyre, M. T., Chamaret, S., Gruest, J., et al. (1983). Isolation of a T-lymphotropic retrovirus from a patient at risk for Acquired Immune Deficiency Syndrome (AIDS). Science, 220(4599), 868–871.
Bozzette, S. A. (2005). Routine screening for HIV infection—timely and cost-effective. New England Journal of Medicine, 352(6), 620–621.
Centers for Disease Control and Prevention [CDC]. (1981). Pneumocystis Pneumonia—Los Angeles. Morbidity and Mortality Weekly Report, 30, 250–252.
CDC. (1981). Kaposi’s sarcoma and Pneumocystis Pneumonia among homosexual men—New York City and California. Morbidity and Mortality Weekly Report, 30, 305–307.
CDC. (1982a). Update on the Acquired Immune Deficiency Syndrome (AIDS)—United States. Morbidity and Mortality Weekly Report, 31, 507–514.
CDC. (1982b). Epidemiologic notes and reports update on Kaposi’s sarcoma and opportunistic infections in previously healthy persons—United States. Morbidity and Mortality Weekly Report, 31(22), 294–301.
CDC. (1982c). Current trends update on Acquired Immune Deficiency Syndrome (AIDS)—United States Weekly. Morbidity and Mortality Weekly Report, 31(37), 507–508, 513–514.
CDC. (1982d). Update on Acquired Immune Deficiency Syndrome (AIDS) among patients with hemophilia A. Morbidity and Mortality Weekly Report, 31(48), 644–646, 652.
CDC. (1985). Current trends revision of the case definition of Acquired Immunodeficiency Syndrome for national reporting—United States. Morbidity and Mortality Weekly Report, 34(25), 373–375.
CDC. (1986a). Current trends update: Acquired Immunodeficiency Syndrome—United States. Morbidity and Mortality Weekly Report, 35(2), 17–21.
CDC. (1986b). Current trends update: Acquired Immunodeficiency Syndrome—United States. Morbidity and Mortality Weekly Report, 35(49), 757–760, 765–766.
CDC. (1987). Revision of case definition of Acquired Immunodeficiency Syndrome for national reporting—United States. Morbidity and Mortality Weekly Report, 36(Suppl.), 1S–15S.
CDC. (1989). Current trends update: Acquired Immunodeficiency Syndrome—United States, 1981–1988. Morbidity and Mortality Weekly Report, 38(14), 229–232, 234–236.
CDC. (1991). 1992 revised classification system for HIV infection and expanded case definition for adolescents and adults. Draft.
CDC. (1992a). 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morbidity and Mortality Weekly Report, 41(RR-17), 1–5.
CDC. (1992b). Guidelines for prophylaxis against Pneumocystis carinii pneumonia for persons infected with human immunodeficiency virus. Morbidity and Mortality Weekly Report, 41(RR-4), 1–11.
CDC. (1994a). Update: Impact of the expanded AIDS surveillance case definition for adolescents and adults on case reporting United States, 1993. Morbidity and Mortality Weekly Report, 43(160–161), 167–170.
CDC. (1994b). Zidovudine for the prevention of HIV transmission from mother to infant. Morbidity and Mortality Weekly Report, 43, 285–287.
CDC. (1999). Guidelines for national Human Immunodeficiency Virus case surveillance, including monitoring for Human Immunodeficiency Virus infection and Acquired Immunodeficiency Syndrome. Morbidity and Mortality Weekly Report, 48(RR13), 1–28.
CDC. (2002). Update: AIDS—United States, 2000. Morbidity and Mortality Weekly Report, 51(27), 592–595.
CDC. (2007). Mother-to-child (perinatal) HIV transmission and prevention. CDC HIV/AIDS Fact Sheet.
CDC. (2008). Revised surveillance case definitions for HIV infection among adults, adolescents, and children aged <18 months and for HIV infection and AIDS among children aged 18 months to <13 years—United States, 2008. Morbidity and Mortality Weekly Report, 57(RR10), 1–8.
CDC. (2013a). HIV/AIDS surveillance report, 2011; vol. 23. Atlanta, GA: Department of Health and Human Services, Centers for Disease Control and Prevention.
CDC. (2013b). HIV testing trends in the United States, 2000–2011. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention.
CDC. (2014a). HIV/AIDS: Basic statistics. Retrieved July 22, 2014, from http://www.cdc.gov/hiv/basics/statistics.html.
CDC. (2014b). Revised surveillance case definition for HIV infection—United States, 2014. Morbidity and Mortality Weekly, 63(RR03), 1–10.
Curran, J. W., & Jaffe, H. W. (2011). AIDS: The early years and CDC’s response. Morbidity and Mortality Weekly Report, 60(4), 64–69.
Easterbrook, P. J., Keruly, J. C., Creagh-Kirk, T., Richman, D. D., Chaisson, R. E., Moore, R. D., et al. (1991). Racial and ethnic differences in outcome in zidovudine treated patients with advanced HIV disease. Journal of the American Medical Association, 266, 2713–2718.
Faria, N. R., Rambaut, A., Suchard, M. A., Baele, G., Bedford, T., Ward, M. J., et al. (2014). The early spread and epidemic ignition of HIV-1 in human populations. Science, 346(6205), 56–61. doi:10.1126/science.1256739.
Farmer, P. (1992). AIDS and accusation: Haiti and the geography of blame. Berkeley: University of California Press.
Fernandez-Cruz, E., Desco, M., Garcia Montes, M., Longo, N., Gonzalez, B., & Zabay, J. M. (1990). Immunological and serological markers predictive of progression to AIDS in a cohort of HIV-infected drug users. Journal of AIDS, 4, 987–994.
Fischl, M. A., Richman, D. D., Hansen, N., Collier, A. C., Carey, J. T., Para, M. F., et al. (1990). The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection: A double blind, placebo controlled trial. Annals of Internal Medicine, 112, 727–737.
Food and Drug Administration [FDA]. (2014a). First rapid home-use HIV kit approved for self-testing. Retrieved September 11, 2014, from http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm310545.htm.
FDA. (2014b). Home access HIV-1 test system. Retrieved January 8, 2015, from http://www.fda.gov/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/PremarketApprovalsPMAs/ucm091475.htm.
Jaffe, H. W., Choi, K., Thomas, P. A., Haverkos, H. W., Auerbach, D. M., Guinan, M. E., et al. (1983). National case control study of Kaposi’s sarcoma and Pneumocystis carinii pneumonia in homosexual men: Part 1, epidemiologic results. Annals of Internal Medicine, 99(2), 145–151.
Lagakos, S., Fischl, M. A., Stein, D. S., Lim, L., & Volberding, P. A. (1991). Effects of zidovudine therapy in minority and other subpopulations with early HIV infection. Journal of the American Medical Association, 266, 2709–2712.
Levine, C. (2009). Ethics and epidemiology in the age of AIDS. In S. S. Coughlin, T. L. Beauchamp, & D. L. Weed (Eds.), Ethics and epidemiology (2nd ed., pp. 204–226). New York: Oxford University Press.
McKay, R. A. (2014). “Patient Zero”: The absence of a patient’s view of the early North American AIDS epidemic. Bulletin of the History of Medicine,. doi:10.1353/bhm.2014.0005.
National Institutes of Health. (1990). State-of-the-art conference on azidothymidine therapy for early HIV infection. American Journal of Medicine, 89, 335–344.
Orasure Technologies. (2014).What is OraQuick? Retrieved September 11, 2014, from http://www.oraquick.com/What-is-OraQuick.
Paltiel, A. D., Weinstein, M. C., Kimmel, A. D., Seage, G. R., Losina, E., Zhang, H., et al. (2005). Expanded screening for HIV in the United States-an analysis of cost-effectiveness. New England Journal of Medicine, 352(6), 586–595.
Poffenberger, K. L. (2000). Development of rapid HIV tests. Blood Products Advisory Committee, 66th Meeting. Silver Spring, MD.
Popovic, M., Sarngadharan, M. G., Read, E., & Gallo, R. C. (1984). Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science, 224(4648), 497–500.
Sanders, G. D., Bayoumi, A. M., Sundaram, V., Biir, S. P., Neukermans, A. B., Ryzdak, C. E., et al. (2005). Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy. New England Journal of Medicine, 352(6), 570–585.
Shilts, R. (1987). And the band played on: People, politics, and the AIDS epidemic. New York: St. Martin’s Press.
The New York Times. (1981). Homosexuals found particularly liable to common virus. Retrieved July 22, 2014, from http://www.nytimes.com/1981/12/10/us/homosexuals-found-particularly-liable-to-common-viruses.html.
Volberding, P. A., Lagakos, S. W., Koch, M. A., Pettinelli, C., Myers, M. W., Booth, D. K., et al. (1990). Zidovudine in asymptomatic human immunodeficiency virus infection: A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. New England Journal of Medicine, 322, 941–949.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Jones, J., Salazar, L. (2016). A Historical Overview of the Epidemiology of HIV/AIDS in the United States. In: Wright, E., Carnes, N. (eds) Understanding the HIV/AIDS Epidemic in the United States. Social Disparities in Health and Health Care. Springer, Cham. https://doi.org/10.1007/978-3-319-34004-3_2
Download citation
DOI: https://doi.org/10.1007/978-3-319-34004-3_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-34002-9
Online ISBN: 978-3-319-34004-3
eBook Packages: Social SciencesSocial Sciences (R0)